beta-lactams has been researched along with Infections, Proteus in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chatzopoulou, F; Malousi, A; Meletis, G; Metallidis, S; Politi, L; Poulou, A; Protonotariou, E; Skoura, L; Tsakris, A | 1 |
| Baptista, AAS; de Souza, M; Kobayashi, RKT; Koga, VL; Menck-Costa, MF; Rocha, SPD; Sanches, MS | 1 |
| Chang, SC; Chen, PC; Huang, IW; Lai, JF; Lauderdale, TL; Shiau, YR; Tan, MC; Wang, HY; Wang, JT | 1 |
| Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH | 1 |
| Dixon, N; Fowler, RC; Geyer, CN; Hanson, ND; Harrison, L; Horiyama, T; Ishii, Y; Moland, ES; Thomson, K; Yoshizumi, A | 1 |
| Comelli, M; Debiaggi, M; Fugazza, G; Migliavacca, R; Nucleo, E; Pagani, L; Spalla, M | 1 |
| Ikeda, F; Ishii, Y; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Saika, T; Yamaguchi, K | 1 |
| Hawser, SP | 1 |
| Abaev, I; Dyatlov, I; Fursova, N; Kartsev, N; Kruglov, A; Pecherskikh, E; Pryamchuk, S; Svetoch, E | 1 |
| Iredell, JR; Partridge, SR; Zong, Z | 1 |
| Yoshida, A | 1 |
| Balbinot, A; Carlino, D; Catavitello, C; D'Antonio, D; Di Berardino, F; Di Bonaventura, G; Febbo, F; Fioritoni, F; Manna, A; Savini, V; Talia, M | 1 |
| Dalhoff, A; Gau, W; Gehl, AE; Lode, H | 1 |
| Girlich, D; Karim, A; Nordmann, P; Spicq, C | 1 |
| Amicosante, G; Giacobone, E; Matti, C; Migliavacca, R; Pagani, L; Pallecchi, L; Romero, E; Rossolini, GM | 1 |
| Fukada, S; Kojo, H; Mine, Y; Nishida, M; Nonoyama, S | 1 |
| Shvidenko, IG | 1 |
1 review(s) available for beta-lactams and Infections, Proteus
| Article | Year |
|---|---|
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections | 2007 |
16 other study(ies) available for beta-lactams and Infections, Proteus
| Article | Year |
|---|---|
Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotyping Techniques; Greece; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Proteus mirabilis; Tertiary Care Centers; Whole Genome Sequencing; Young Adult | 2020 |
Genotypic and phenotypic profiles of virulence factors and antimicrobial resistance of Proteus mirabilis isolated from chicken carcasses: potential zoonotic risk.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; Chickens; Drug Resistance, Bacterial; Humans; Meat; Microbial Sensitivity Tests; Poultry Diseases; Proteus Infections; Proteus mirabilis; Virulence Factors; Zoonoses | 2019 |
Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus Infections; Proteus mirabilis; Taiwan; Urinary Tract Infections; Young Adult | 2014 |
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine | 2016 |
IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis.
Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Hydrolysis; Integrons; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; United States | 2016 |
Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; beta-Lactamases; beta-Lactams; Biofilms; Cell Line; Drug Resistance, Bacterial; Haplorhini; Humans; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis | 2010 |
Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA; Time Factors | 2010 |
Superior in vitro activity of ertapenem and piperacillin/tazobactam against recent clinical isolates of Proteus mirabilis from intra-abdominal infections (SMART 2009-2010).
Topics: Abdominal Abscess; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis | 2011 |
The novel CTX-M-116 β-lactamase gene discovered in Proteus mirabilis is composed of parts of the CTX-M-22 and CTX-M-23 genes.
Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Databases, Nucleic Acid; Escherichia coli; Escherichia coli Proteins; Humans; Molecular Sequence Data; Protein Isoforms; Proteus Infections; Proteus mirabilis; Recombination, Genetic; Sequence Homology, Nucleic Acid | 2013 |
RmtC 16S rRNA methyltransferase in Australia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S | 2008 |
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Pressure Ulcer; Proteus Infections; Proteus mirabilis; Wound Infection | 2008 |
Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biological Availability; Disease Models, Animal; Drug Therapy, Combination; Enzyme Induction; Exudates and Transudates; Female; Kinetics; Proteus Infections; Proteus vulgaris; Rats; Rats, Inbred Strains | 1982 |
Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli.
Topics: beta-Lactams; Cephalosporinase; Escherichia coli; Escherichia coli Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Plasmids; Proteus Infections; Proteus mirabilis | 2000 |
Emerging extended-spectrum beta-lactamases in Proteus mirabilis.
Topics: beta-Lactamases; beta-Lactams; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis | 2002 |
Nocardicin A, a new monocyclic beta-lactam antibiotic V. In vivo evaluation.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbenicillin; Cefazolin; Escherichia coli Infections; Kidney; Liver; Male; Mice; Penicillin Resistance; Proteus Infections; Pseudomonas Infections; Serratia marcescens | 1977 |
[Sensitivity to beta-lactam and aminoglycoside antibiotics of clinical Proteus strains as dependent upon on their species classification and the source of their isolation].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriuria; beta-Lactams; Drug Resistance, Microbial; Feces; Humans; Microbial Sensitivity Tests; Proteus; Proteus Infections; Proteus mirabilis; Proteus vulgaris; Species Specificity | 1987 |